SCHEMBL6038446

SCHEMBL6038446

O=Nc1ccccc1C(=O)c1ccccc1N=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ MAPT P10636 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ GAA P10253 3/20 0.41
▸ TP53 P04637 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ KDM4E B2RXH2 6/20 0.41
▸ HPGD P15428 6/20 0.41
▸ LMNA P02545 3/20 0.41
▸ HTT P42858 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ AKR1C3 P42330 1/20 0.38
▸ IDE P14735 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CDC25B P30305 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1535311 0.87 AKR1C3 (0.57) ALDH1A1MAPTGAAKDM4ELMNA
SCHEMBL7184551 0.83 CDC25B (0.50) ALDH1A1ALOX15MAPTSMN1; SMN2TSHR
SCHEMBL1081928 0.83 ALDH1A1 (0.59) ALDH1A1ALOX15MAPTSMN1; SMN2GAA
SCHEMBL7196004 0.82 LIG1 (0.61) ALDH1A1MAPTGAAKDM4EHPGD
SCHEMBL7188437 0.82 SRD5A2 (0.55) MAPTGAATP53TSHRKDM4E
SCHEMBL16334491 0.82 ALDH1A1 (0.53) ALDH1A1MAPTSMN1; SMN2GAAKDM4E
SCHEMBL7185592 0.82 MEN1 (0.57) ALDH1A1ALOX15MAPTSMN1; SMN2GAA
SCHEMBL1718336 0.81 ALDH1A1 (0.40) ALDH1A1ALOX15MAPTSMN1; SMN2GAA
SCHEMBL12567347 0.81 CA12 (0.41) ALDH1A1ALOX15MAPTSMN1; SMN2GAA
SCHEMBL10025655 0.81 ALDH1A1 (0.39) ALDH1A1ALOX15MAPTSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060210452-A1 Very large scale immobilized polymer synthesis AFFYMAX TECHNOLOGIES, N.V., A NETHERLANDS ANTILLES CORPORATION 2006-09-21 — — US disclosed
US-20060194258-A1 Polypeptide array synthesis AFFYMETRIX, INC. (US) 2006-08-31 — — US disclosed
US-7087732-B2 Nucleotides and analogs having photoremovable protecting groups AFFYMETRIX, INC. (US) 2006-08-08 — — US disclosed
US-6955915-B2 Apparatus comprising polymers AFFYMETRIX, INC. (US) 2005-10-18 — — US disclosed
US-20050208537-A1 Very large scale immobilized polymer synthesis AFFYMETRIX, INC. (US) 2005-09-22 — — US disclosed
US-6919211-B1 Polypeptide arrays AFFYMETRIX, INC. (US) 2005-07-19 — — US disclosed
US-20050153362-A1 Polymer arrays PIRRUNG MICHAEL C (US) 2005-07-14 — — US disclosed
US-20050153363-A1 Polymer arrays PIRRUNG MICHAEL C (US) 2005-07-14 — — US disclosed
US-20050118706-A1 Polymer arrays AFFYMETRIX, INC. (US) 2005-06-02 — — US disclosed
US-20050095652-A1 Apparatus comprising polymers AFFYMETRIX, INC. (US) 2005-05-05 — — US disclosed
US-5889165-A Photolabile nucleoside protecting groups AFFYMETRIX, INC. (US) 1999-03-30 — — US disclosed
US-5753788-A Photolabile nucleoside protecting groups AFFYMETRIX, INC. (US) 1998-05-19 — — US disclosed
US-5744101-A Photolabile nucleoside protecting groups AFFYMAX TECHNOLOGIES N.V. (GB) 1998-04-28 — — US disclosed
US-5744305-A Arrays of materials attached to a substrate AFFYMETRIX, INC. (US) 1998-04-28 — — US disclosed
US-5489678-A 6-NITRO-1,3-BENZOXAZOL-5-YL ALKYLOXY PROTECTIVE GROUP ON THE 5' POSITION OF A DEOXYNUCLEOSIDE; COMPUTERIZED SOLID PHASE SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (NL) 1996-02-06 — — US disclosed
US-5424186-A Biosynthesis of oligonucleotides on solid substrate by irradiation of predefined segments to remove blocking agents; then coupling with nucleotide AFFYMAX TECHNOLOGIES N.V. (AN) 1995-06-13 — — US disclosed
WO-1994010128-A1 NOVEL PHOTOREACTIVE PROTECTING GROUPS AFFYMAX TECHNOLOGIES N.V. (AN) 1994-05-11 — — WO disclosed
EP-0562025-A4 — — 1994-03-30 — — EP disclosed
EP-0562025-A1 VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (AN) 1993-09-29 — — EP disclosed
WO-1992010092-A1 VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (AN) 1992-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194258-A1 Polypeptide array synthesis MRPL21, NGLY1, PSAP ALDH1A1 4233/4885ALOX15 4559/4885MAPT 2780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback